Статья

Immunity to COVID-19 and issues of screening for SARS-Cov-2 antibodies

N. Mayanskiy,
2020

This paper briefly presents the known data on the immune response to SARS-CoV-2, and also analyzes the possibilities and limitations of serological testing for antibodies that should be accounted for when planning population studies and interpreting their results.

Цитирование

Похожие публикации

Версии

  • 1. Version of Record от 2020-06-23

Метаданные

Об авторах
  • N. Mayanskiy
    Pirogov Russian National Research Medical University, Moscow, Russia
Название журнала
  • Bulletin of Russian State Medical University
Выпуск
  • (3)2020
Страницы
  • 25-27
Издатель
  • Pirogov Russian National Research Medical University
Тип документа
  • journal article
Тип лицензии Creative Commons
  • CC BY
Правовой статус документа
  • Свободная лицензия
Источник
  • dimensions